CURRENC Group and ARC Group Jointly Launch $100 Million AI-Focused Infrastructure & Investment Fund
- Accelerating AI Data Center, Green Energy, and Computing Power Development with Initial Investment Venture Accelerating AI Data Center, Green Energy, and Computing Power Development with Initial Investment Venture
- 03/18/2025
|
CURRENC Group and ARC Group Jointly Launch $100 Million AI-Focused Infrastructure & Investment Fund
- Accelerating AI Data Center, Green Energy, and Computing Power Development with Initial Investment Venture Accelerating AI Data Center, Green Energy, and Computing Power Development with Initial Investment Venture
- 03/18/2025
|
CURRENC to Develop 500MW Hyperscale AI Data Center in Malaysia
- Groundbreaking Infrastructure Project Propelling Global Financial Institutions' AI Innovation Groundbreaking Infrastructure Project Propelling Global Financial Institutions' AI Innovation
- 03/18/2025
|
CURRENC to Participate in the AI Panel at the 37th Annual ROTH Conference
- SINGAPORE, March 13, 2025 (GLOBE NEWSWIRE) -- CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech pioneer empowering financial institutions worldwide with artificial intelligence (AI) solutions, today announced that the Company's Founder and Executive Chairman, Alex Kong, will participate in the 37th Annual Roth Conference, taking place March 16-18, 2025, at the Laguna Cliffs Marriott in Dana Point, California.
- 03/13/2025
|
CURRENC Debuts SEAMLESS AI Call Centre Solutions
- SINGAPORE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech and digital remittance pioneer serving millions of unbanked and underbanked individuals in Southeast Asia and beyond, today announced the launch of its SEAMLESS AI Call Centre Solutions, a suite of AI-powered tools designed to reduce costs, increase efficiency and boost customer satisfaction for banks, insurance companies, telecommunications companies, government agencies, cryptocurrency exchanges and other financial institutions.
- 01/08/2025
|
CURRENC Group Inc. Announces Third Quarter 2024 Unaudited Financial Results
- SINGAPORE, Nov. 29, 2024 (GLOBE NEWSWIRE) -- CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech and digital remittance pioneer serving millions of unbanked and underbanked individuals in Southeast Asia and beyond, recently announced its unaudited financial results for the third quarter ended September 30, 2024.
- 11/29/2024
|
CURRENC Rings Nasdaq Closing Bell in Honor of Listing
- NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) -- CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech and digital remittance pioneer serving millions of unbanked and underbanked individuals in Southeast Asia and beyond, today announced that the Company's management celebrated its recent listing with a Closing Bell Ceremony at Nasdaq MarketSite in Times Square this afternoon. CURRENC began trading on the Nasdaq on September 3, 2024, after completing its business combination with INFINT Acquisition Corporation (formerly NYSE: IFIN), which was facilitated by ARC Group Limited.
- 09/26/2024
|
Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
- New Branding Reflects Company's Commitment to the Future of Wellness SHERMAN OAKS, CA / ACCESSWIRE / August 8, 2023 / Avenir Wellness Solutions, Inc. (OTC Pink:CURR) ("Avenir" or the "Company"), a proprietary broad platform and wellness technology company, today announced that it has received regulatory approval to officially change its ticker symbol from "CURR" to "AVRW" effective at the stock market opening on August 9, 2023. The ticker symbol change follows the corporate name change to "Avenir Wellness Solutions, Inc." in October 2022.
- 08/08/2023
|
Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available
- Presentation TODAY at 1:30PM Pacific Time (4:30 PM Eastern Time) SHERMAN OAKS, CA / ACCESSWIRE / April 26, 2023 / Avenir Wellness Solutions, Inc. ("Avenir Wellness") (OTCQB:CURR), a proprietary broad platform technology and wellness company, announced today that it will be presenting at the Planet MicroCap Showcase TODAY Wednesday, April 26, 2023, at 1:30 PM Pacific Time (4:30 PM Eastern Time). The Company's CEO, Nancy Duitch, will be presenting.
- 04/26/2023
|
Avenir Wellness Solutions to Present at Investor Summit Group's Q4 Conference
- Sherman Oaks, California--(Newsfile Corp. - November 10, 2022) - Avenir Wellness Solutions, Inc. (f/k/a CURE Pharmaceutical Holding Corp.) (OTCQB: CURR) today announced that CEO Nancy Duitch will be attending the Q4 Investor Summit live in NYC at the Sheraton Times Square.
- 11/10/2022
|
Cure Pharmaceutical Holding to Present at the LD Micro Main Event XV
- Presentation on Tuesday, October 25 at 12:30 PM Pacific Time (3:30 PM Eastern)Oxnard, California--(Newsfile Corp. - October 24, 2022) - Cure Pharmaceutical Holding Corp. (OTCQB: CURR) ("CURE"), a broad wellness platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems, announced today that it will be presenting at the 12th annual Invitational on Tuesday October 25 at 12:30 PM Pacific Time (3:30 PM Eastern) at the Luxe Sunset Boulevard Hotel. Nancy Duitch, CEO will be giving the presentation.
- 10/24/2022
|
CURE Pharmaceutical Q2 2021 Revenue Spikes 700% After Increased Sales From Seba Labs Products Including A CVS Deal
- Pharmaceutical company CURE Pharmaceutical Holding Corp. (OTC:CURR) announced earnings results on Tuesday for the quarter ended June 30, revealing revenue of $2.1 million. That's a year-over-year increase of 700%.
- 08/18/2021
|
CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference
- OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness markets, announced today that its Chief Business Officer Jonathan Berlent will participate in a virtual presentation at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on Thursday, June 17. "The potential therapeutic benefits of psychedelics to treat m
- 06/15/2021
|
Federally Compliant Medical Cannabis In The US? One Company Is Doing It
- CURE Pharmaceutical (OTC:CURR) has signed an agreement with Biopharmaceutical Research Company (BRC) to produce federally compliant medical cannabis, CBD and THC products. BRC will provide the cannabinoid ingredients and CURE will use them to begin the development of CBD and THC oral thin films for CURE's clinical studies targeted at advancing veteran health.
- 06/11/2021
|
CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health
- OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has signed a partnership agreement with Biopharmaceutical Research Company, (BRC), an active Drug Enforcement Administration (DEA) license holder, to produce federally-compliant cannabis-based medical products. Currently, CURE uses its Schedule 1 DEA license for the development of Cannabis (THC) oral film products and othe
- 06/10/2021
|
CURE Pharmaceutical First Quarter Revenue Quadruples to $1.5 million; Company Expands Clinical Pipeline to Include Psychedelics
- OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, reported its financial results and provided an operational update for the first quarter ended March 31, 2021. First Quarter 2021 and subsequent weeks highlights: Total revenue rose more than 400% to $1.5 million compared with a year ago and gross profit rose in line with revenue growth. Received approval for an Investigational New Drug (IND) appl
- 05/17/2021
|
CURE Pharmaceutical Receives ISO Certification for Laboratory and Manufacturing Facility
- LOS ANGELES--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has secured International Organization for Standardization (ISO) 9001 certification for its Oxnard, Calif., manufacturing and research facility. ISO 9001 certification recognizes excellence in quality management standards of an organization that places an emphasis on its customers, the motivation and
- 05/13/2021
|
CURE Pharmaceutical Launches Psychedelic Oral Film Program Targeting the Treatment of Mental Health Disorders
- OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched a new initiative for the clinical development of psychedelic compounds such as psilocybin, LSD, and MDMA for the treatment of various mental health disorders. Utilizing CURE's patented oral film platform CUREfilm® for precision dosing, the company intends to optimize the absorption an
- 03/16/2021
|
CURE Pharmaceutical's Subsidiary Sera Labs Launches National Television, Radio & Digital Advertising Campaign for Nutri-Strips Sleep A.S.A.P.
- LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space today announced that its subsidiary Sera Labs has launched a robust national advertising campaign for its Nutri-Strips thin-film product Sleep A.S.A.P.™ which offers a solution to America's sleep problem. The global market for sleep ai
- 03/03/2021
|
CURE Pharmaceutical Announces Promotions and Additions to Board of Directors
- OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today updates and additions to its Board of Directors. After a dedicated run as Chairman of the Board, William Yuan is stepping down and will continue to serve the Company as an advisor and Chairman Emeritus. Rubén José King-Shaw Jr, a highly qualified and respected member of
- 02/11/2021
|
Sera Labs Unveils ImmunD₃™ an Important New Offering to the Nutri-Strips™ Product Line; Launches New Digital E-commerce Website to Amplify Consumer Awareness
- LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--According to the National Institute of Health (NIH) more than 50 percent of people worldwide have Vitamin D insufficiency. In response, Sera Labs, Inc., a wholly owned subsidiary of CURE Pharmaceutical Holdings (OTCQB: CURR), announced today that it is unveiling “ImmunD₃,” a convenient, science-backed oral thin-film that provides a weekly dose of Vitamin D (40,000 IU) as a part of its Nutri-Strips™ line of novel and innovative vitamins and suppleme
- 02/10/2021
|
Sera Labs, Inc. Wins Prestigious Retail Excellence Award
- LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)---- $CURR #CBD--The retailers have spoken! Sera Labs, Inc., the wholly owned subsidiary of CURE Pharmaceutical Holdings (OTCQB: CURR), announced today they have won the coveted Retail Excellence (REX Award) for Natural Products. The Rex Awards have a long history of recognizing, and honoring category leaders in the industry. Sera Labs, the premiere health, wellness and anti-aging CBD and plant-based skincare company beat out hundreds of nominees for this highly so
- 02/02/2021
|
CURE Pharmaceutical's® Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a Revolutionary Oral Thin Film Strip Technology
- LOS ANGELES & OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding (OTCQB: CURR) wholly owned subsidiary Sera Labs is challenging the status quo of the health and wellness sector by bringing innovative products to market using groundbreaking technology and superior ingredients. As a trusted industry leader that continues to offer consumer solutions, Sera Lab's is launching the Nutri-Strips brand with a multi-channel advertising and marketing strategy beginning initially with “Sleep A.S.
- 10/29/2020
|
